Stonepine Capital Management as of Dec. 31, 2019
Portfolio Holdings for Stonepine Capital Management
Stonepine Capital Management holds 23 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amarin Corporation | 23.2 | $33M | 1.6M | 21.44 | |
| Iveric Bio | 17.9 | $26M | 3.0M | 8.58 | |
| Affimed Therapeutics B V | 7.7 | $11M | 4.0M | 2.74 | |
| Oxford Immunotec Global | 7.3 | $11M | 631k | 16.60 | |
| Adamas Pharmaceuticals | 5.9 | $8.5M | 2.2M | 3.79 | |
| Neos Therapeutics | 5.1 | $7.3M | 4.9M | 1.51 | |
| Cti Biopharma | 4.1 | $5.9M | 3.8M | 1.58 | |
| Xoma Corp Del (XOMA) | 3.8 | $5.5M | 201k | 27.30 | |
| Opiant Pharmaceuticals | 3.4 | $4.8M | 334k | 14.40 | |
| Evolus (EOLS) | 3.4 | $4.8M | 395k | 12.17 | |
| Apollo Endosurgery | 3.3 | $4.7M | 1.7M | 2.85 | |
| Cumberland Pharmaceuticals (CPIX) | 3.2 | $4.6M | 896k | 5.15 | |
| Htg Molecular Diagnostics | 2.3 | $3.3M | 4.8M | 0.70 | |
| Aegerion Pharmaceuticals Inc note 5.000% 4/0 | 2.0 | $2.8M | 3.0M | 0.95 | |
| Noveliontherapeuti.. | 1.9 | $2.8M | 3.9M | 0.71 | |
| Aptevo Therapeutics Inc apvo | 1.9 | $2.7M | 4.2M | 0.65 | |
| Catalyst Biosciences | 1.5 | $2.1M | 307k | 6.81 | |
| Chiasma | 0.6 | $911k | 184k | 4.96 | |
| Strongbridge Bioph shs usd | 0.6 | $903k | 432k | 2.09 | |
| Scynexis | 0.4 | $555k | 609k | 0.91 | |
| Interpace Biosciences (IDXG) | 0.3 | $472k | 944k | 0.50 | |
| Restorbio | 0.1 | $122k | 82k | 1.49 | |
| Acer Therapeutics | 0.1 | $80k | 20k | 4.00 |
